Señales en vivo de HEMC.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (5 dic 2023 @ 10:58):

Hemcheck Sweden AB (publ) operates as a medical technology company in Sweden. The company develops and commercializes Helge, which detects hemolysis in blood samples at the point of care...

Stats
Volumen de hoy	251 643
Volumen promedio	93 083.00
Capitalización de mercado	8.63M
EPS	SEK-0.100 ( 2023-09-30 )
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-1.513
ATR14	SEK0.0530 (21.20%)

Volumen Correlación

Largo: 0.04 (neutral)

Corto: 0.72 (moderate)

Signal:(51.601) Neutral

Hemcheck Sweden AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hemcheck Sweden AB (publ) Correlación - Moneda/Commodity

0.06
( neutral )

0.32
( neutral )

-0.23
( neutral )

0.01
( neutral )

-0.05
( neutral )

0.22
( neutral )

Hemcheck Sweden AB (publ) Finanzas

Annual	2022
Ingresos:	SEK1.32M
Beneficio Bruto:	SEK3.64M (276.02 %)
EPS:	SEK-0.950

FY	2022
Ingresos:	SEK1.32M
Beneficio Bruto:	SEK3.64M (276.02 %)
EPS:	SEK-0.950

FY	2021
Ingresos:	SEK1.12M
Beneficio Bruto:	SEK3.02M (269.32 %)
EPS:	SEK-0.888

FY	2020
Ingresos:	SEK306 810
Beneficio Bruto:	SEK2.64M (859.96 %)
EPS:	SEK-0.740

Financial Reports:

No articles found.

Hemcheck Sweden AB (publ)

Hemcheck Sweden AB (publ) operates as a medical technology company in Sweden. The company develops and commercializes Helge, which detects hemolysis in blood samples at the point of care. It serves emergency departments in the European Union and the United States. The company was founded in 2010 and is based in Karlstad, Sweden.